.png?sfvrsn=1e7191c0_3)
glp 1 menopause symptoms GLP-1s, Obesity, and Menopause: Benefits and Risks Let's talk about GLP-1 medications
Description
Increasing scientific data on the obesity-pancreatic diseases conundrum also necessitates the need for integrating obesity-related markers into risk stratification and prognostic models, as well as exploring targeted therapeutic strategies in obesity-associated pancreatic disease.
Compelling CVOT data: Ultimately, health systems attribute value to cardiovascular outcomes, not weight loss on its own
UChicago Medicine bariatric surgeon Vanessa Buie, MD, MBA, explains the benefits of surgery as a long-term alternative to taking GLP-1 medications
No announcement on the list price yet
Learn what this looks like.
